Senti Biosciences, Inc.SNTINASDAQ
Loading
Operating Income Growth AcceleratingAccelerating
Percentile Rank58
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Percentile
P58
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
PeriodValue
Q3 2025-0.89%
Q2 2025-2.45%
Q1 2025-1.42%
Q4 2024-6.26%
Q3 2024-13.92%
Q2 202418.07%
Q1 202411.54%
Q4 202358.00%
Q3 2023-188.89%
Q2 2023-1.50%
Q1 202325.24%
Q4 2022-35.72%
Q3 202232.26%
Q2 2022-85.16%
Q1 2022-8.02%
Q4 20214.71%
Q3 2021-26.98%
Q2 2021-763567.23%
Q1 202199.98%
Q4 20200.00%